Zixuan Wang , Bohan Yin , Yuechi Hou , Yongqiang Zhao , Libin Chen , Tao Ren , Weifeng Yuan
{"title":"YTHDF2 promotes m6A-modified HSPA2 translation to restrict Newcastle Disease Virus","authors":"Zixuan Wang , Bohan Yin , Yuechi Hou , Yongqiang Zhao , Libin Chen , Tao Ren , Weifeng Yuan","doi":"10.1016/j.vetmic.2026.110960","DOIUrl":null,"url":null,"abstract":"<div><div>Newcastle disease virus (NDV), a highly contagious avian pathogen, causes devastating economic losses in poultry worldwide, yet the role of epitranscriptomic regulators in its pathogenesis remains poorly defined. Here we demonstrate that the m6A reader protein YTHDF2 functions as a potent antiviral effector against NDV. Through integrated functional genomics and multi-omics approaches, we establish that YTHDF2 deficiency significantly enhances NDV replication, while its overexpression suppresses viral propagation. Temporal transcriptomics and machine learning algorithms converged on HSPA2, ATF3, and IRF9 as high-confidence YTHDF2-regulated targets during infection, with HSPA2 emerging as the principal mechanistic mediator. Mechanistically, YTHDF2 directly binds m6A-modified sites within the HSPA2 coding sequence to augment its translational efficiency, as validated by RNA immunoprecipitation, isothermal titration calorimetry, and m6A-modified reporter assays. HSPA2 overexpression reduced NDV nucleoprotein levels by 68–74%, establishing its direct antiviral function. Crucially, this YTHDF2-HSPA2 axis operates independently of classical innate immune pathways, as transcriptomics revealed intact induction of antiviral genes in YTHDF2-knockout cells. Our findings unveil a previously unrecognized epitranscriptome-governed antiviral strategy wherein YTHDF2 amplifies host defense through selective translational enhancement of m6A-modified effector transcripts. This paradigm extends beyond canonical RNA decay functions of YTHDF2 and identifies the HSPA2 chaperone as a novel restriction factor against paramyxoviruses, offering new avenues for targeted antiviral interventions.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"316 ","pages":"Article 110960"},"PeriodicalIF":2.8000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S037811352600091X","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Newcastle disease virus (NDV), a highly contagious avian pathogen, causes devastating economic losses in poultry worldwide, yet the role of epitranscriptomic regulators in its pathogenesis remains poorly defined. Here we demonstrate that the m6A reader protein YTHDF2 functions as a potent antiviral effector against NDV. Through integrated functional genomics and multi-omics approaches, we establish that YTHDF2 deficiency significantly enhances NDV replication, while its overexpression suppresses viral propagation. Temporal transcriptomics and machine learning algorithms converged on HSPA2, ATF3, and IRF9 as high-confidence YTHDF2-regulated targets during infection, with HSPA2 emerging as the principal mechanistic mediator. Mechanistically, YTHDF2 directly binds m6A-modified sites within the HSPA2 coding sequence to augment its translational efficiency, as validated by RNA immunoprecipitation, isothermal titration calorimetry, and m6A-modified reporter assays. HSPA2 overexpression reduced NDV nucleoprotein levels by 68–74%, establishing its direct antiviral function. Crucially, this YTHDF2-HSPA2 axis operates independently of classical innate immune pathways, as transcriptomics revealed intact induction of antiviral genes in YTHDF2-knockout cells. Our findings unveil a previously unrecognized epitranscriptome-governed antiviral strategy wherein YTHDF2 amplifies host defense through selective translational enhancement of m6A-modified effector transcripts. This paradigm extends beyond canonical RNA decay functions of YTHDF2 and identifies the HSPA2 chaperone as a novel restriction factor against paramyxoviruses, offering new avenues for targeted antiviral interventions.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.